Pharmacologic management of pain in patients with Chikungunya: a guideline.

@article{Brito2016PharmacologicMO,
  title={Pharmacologic management of pain in patients with Chikungunya: a guideline.},
  author={Carlos Alexandre Antunes de Brito and Ana Karla Arraes von Sohsten and Clezio Cordeiro de S{\'a} Leit{\~a}o and Rita de C{\'a}ssia Coelho Moraes de Brito and Lilian David de Azevedo Valadares and Caroline Ara{\'u}jo Magnata da Fonte and Zelina Barbosa de Mesquita and Rivaldo Ven{\^a}ncio da Cunha and Kleber Giovanni Luz and Helena Maria Carneiro Le{\~a}o and Cecilia Coelho Moraes de Brito and L{\'i}via Carla Vinhal Frutuoso},
  journal={Revista da Sociedade Brasileira de Medicina Tropical},
  year={2016},
  volume={49 6},
  pages={668-679}
}
From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS